Most recent posts

  XML Feeds

Search

« MedBen University Season Rolls out with RoundtablesDelayed Again . . . Cadillac Tax Postponed Until 2022 »

Treatment Advances, Regular Screenings Reduce Breast Cancer Mortality

01/28/18

  11:14:00 pm, by MedBen5   , 238 words,  
Categories: American Health Care Act

Treatment Advances, Regular Screenings Reduce Breast Cancer Mortality

pink ribbon

A focus on preventive care and breakthroughs in screening and treatment reduced breast cancer deaths by 49% in 2012, compared with a 37% reduction in 2000, a new study finds.

"Advances in screening and treatment are saving lives," said lead researcher Sylvia Plevritis, a professor of radiology and biomedical data science at the Stanford University School of Medicine. "Here's an example that all this investment in research and discovery has had a real benefit. This has translated into making a difference."

The reduction in breast cancer deaths has also coincided with the rise in employer wellness programs like MedBen WellLiving. From its inception, WellLiving has emphasized the importance of regular cancer screenings based on age and gender... and we're pleased to assist employers in their efforts to help employees achieve better health and realize a higher quality of life. WellLiving recommends that women start getting mammograms at age 40 every two years until their physician decides not to order the screening.

Encouraging preventive care in the workplace offers physical and financial benefits alike. Not only do non-invasive (stage 0) and early stage (I and II) breast cancers have a better prognosis than cancer in its later stages (III and IV), which could possibly even save a life, early stage detection can save a health plan hundreds of thousands of dollars in treatment costs.

Learn how you can make a real difference by contacting MedBen Vice President of Sales & Marketing Brian Fargus at bfargus@medben.com.

No feedback yet